Artivion | CRY - Ebit



金融业
股票价格
USD
资产
USD 883.16M
现金及等价物
USD 55.76M
销售成本
USD 42.85M
流动资产
USD 357.52M
流动负债
USD 92.7M
债务
USD 317.78M
EBIT
USD 4.79M
EBITDA
USD 22.72M
员工
1.5K
EPS每股收益
USD -0.02
股本和储备
USD 450.47M
销售毛利
USD 73.14M
债务利息支出
USD 5.53M
利息收入
USD -0.05
贷款资金
USD 215.35M
市值
USD 1.11B
净收入
USD 2.42M
营业费用
USD 111.2M
营业利润
USD 4.79M
普通股股本
USD 47.84M
PE价格收益
212.38
税前利润
USD 11.4M
销售收入
USD 115.99M
销售和管理费用
USD 55.75M
股票
USD 98M
贸易债权人
USD 18.34M
应收帐款人
USD 103.68M


Ebit 更改 日
Abbott USD 2.13B 281M 2026-06
Accuray USD 11.38M 12.71M 2024-09
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 9.66M 9.14M 2026-06
Baxter International USD 276M 210M 2026-06
Becton, Dickinson and Co. USD 627M 36M 2026-03
Boston Scientific USD 1.24B 190M 2026-06
Edwards Lifesciences USD 519.5M 4.8M 2026-06
Integra LifeSciences USD 41.29M 29.82M 2026-06
J&J USD 7.48B 860M 2026-06
Mesa Laboratories USD 4.45M 2.5M 2024-09
Orthofix International USD 6.12M 1.91M 2025-12
Pfizer USD -180M 5.16B 2026-06
ResMed USD 505.67M 8.07M 2026-03
Stryker USD 1.79B 687M 2026-06
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 37.03M 686K 2026-03
Terumo JPY 31.45B 12.43B 2026-03
Trinity Biotech USD -1.3M 8.72M 2025-12